Related Experiment Videos
Clinical and laboratory factors underlying refractoriness to platelet transfusions
1Department of Pathology, University of Alabama at Birmingham 35233-7331, USA.
Journal of Clinical Apheresis
|January 1, 1996
Summary
Identifying the cause of platelet transfusion refractoriness is key. Utilizing single donor platelets (SDP) over random donor platelets (RDP) can improve patient outcomes and transfusion efficiency.
Area of Science:
- Transfusion Medicine
- Hematology
Background:
- Platelet transfusion refractoriness presents a significant clinical challenge.
- Identifying the specific cause of refractoriness guides optimal patient management.
Purpose of the Study:
- To evaluate the role of single donor platelets (SDP) in managing platelet transfusion refractoriness.
- To compare the advantages of SDP with random donor platelets (RDP).
Main Methods:
- Analysis of clinical and laboratory factors contributing to refractoriness.
- Review of outcomes data comparing SDP and RDP utilization.
Main Results:
- SDP offer advantages like crossmatching potential and reduced donor exposures.
- RDP's perceived benefits of cost and availability may be offset by other factors.
- Increased reliance on SDP can decrease platelet utilization, resource consumption, and wastage.
Conclusions:
- Optimal management of refractory patients involves appropriate use of SDP and crossmatching.
- Shifting towards SDP improves transfusion practice quality and resource management.